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The ATG8 family of proteins regulates autophagy in a variety of ways. Recently, ATG8s were demonstrated to conjugate
directly to cellular proteins in a process termed “ATG8ylation,”which is amplified by mitochondrial damage and antagonized by
ATG4 proteases. ATG8s may have an emerging role as small protein modifiers.
ATG8 proteins directly conjugate to
cellular proteins
Autophagy describes the capture of intra-
cellular material by autophagosomes and
their delivery to lysosomes for destruction
(Kaur and Debnath, 2015). This process ho-
meostatically remodels the intracellular
environment and is necessary for an orga-
nism to overcome starvation (Kaur and
Debnath, 2015). The autophagy pathway is
coordinated by autophagy-related (ATG)
proteins that are controlled by diverse post-
translational modifications (e.g., phosphor-
ylation, acetylation, ubiquitination, and
lipidation; Ichimura et al., 2000; McEwan
and Dikic, 2011). Recently, a previously un-
characterized post-translational modifica-
tion termed “ATG8ylation” was uncovered
(Agrotis et al., 2019; Nguyen et al., 2021).
ATG8ylation is the direct covalent attach-
ment of the small ubiquitin-like family of
ATG8 proteins to cellular proteins (Agrotis
et al., 2019; Nguyen et al., 2021). Until now,
the only known instances of ATG8 conju-
gation to proteins were of a transient na-
ture, as E1- and E2-like intermediates with
ATG7 and ATG3, respectively, as a way of
ligating ATG8 to the lipid phosphatidyl-
ethanolamine during autophagy (Ichimura
et al., 2000). Therefore, ATG8ylation may
represent an underappreciated regulatory
mechanism for many cellular proteins that
coordinate pathways such as mitophagy.
ATG8s play many roles in the
autophagy pathway
During canonical autophagy, the ATG8
family (comprising LC3A, -B, and -C and
GABARAP, -L1, and -L2) undergoes molec-
ular processing that concludes with their
attachment to phosphatidylethanolamine,
enabling proper construction of autophago-
somes and subsequent autophagosome–
lysosome fusion (Nguyen et al., 2016). The
ATG4 family of cysteine proteases (ATG4A,
-B, -C, and -D) cleaves ATG8 proteins im-
mediately after a conserved glycine residue
in their C terminus in a process dubbed
“priming,” which leads to the formation of
ATG8-I (Skytte Rasmussen et al., 2017;
Tanida et al., 2004). ATG7 then attaches to
the exposed glycine residue of ATG8-I via a
thioester linkage to form an E1 ubiquitin-
like complex that transfers ATG8-I to
ATG3 in a similar way to generate an E2-
like complex (Ichimura et al., 2000). The
ATG5–ATG12–ATG16L1 complex then cata-
lyzes the E3-like transfer of ATG8-I from
ATG3 to phosphatidylethanolamine to form
ATG8-II, which is the lipidated species that
is incorporated into double membrane–
bound compartments such as autophago-
somes (Hanada et al., 2007). The lipidation
of ATG8s and their recruitment to the
phagophore are not essential for the for-
mation of autophagosomes but are impor-
tant for phagophore expansion, the selective
capture of autophagic substrates, and
autophagosome–lysosome fusion (Kirkin
and Rogov, 2019; Nguyen et al., 2016). In-
triguingly, ATG8 lipidation is multifaceted,
as ATG8s can be alternatively lipidated with
phosphatidylserine (instead of phosphati-
dylethanolamine) to enable their recruitment
to single membrane–bound compartments
during LC3-associated phagocytosis, in-
fluenza infection, and lysosomal dysfunc-
tion (Durgan et al., 2021).
The discovery of ATG8ylation
Key insights into ATG8ylation came from
the observation that various ATG8s form
high-molecular-weight species in cells fol-
lowing the expression of their primed forms
that have their C-terminal glycine exposed
(for example, LC3B-G), bypassing the need
for cleavage by ATG4 (Agrotis et al., 2019;
Nguyen et al., 2021). Indeed, on an immu-
noblot, ATG8+ “smears” resemble that of
ubiquitinated proteins (Agrotis et al., 2019;
Nguyen et al., 2021). Traditionally, in
the autophagy field, ATG8+ smears were
thought to arise from poor antibody speci-
ficity. However, in light of recent findings,
this widely accepted interpretation has been
challenged, given that ATG8+ smears are
enriched following ATG8 overexpression
and disappear in the absence of ATG8s
(Agrotis et al., 2019; Nguyen et al., 2021).
Smearing has also been detected after
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immunoprecipitation of epitope-tagged ATG8s
from cell extracts under denaturing con-
ditions, ruling out noncovalent interac-
tions accounting for this upshift (Agrotis
et al., 2019; Nguyen et al., 2021). Further,
smearing is not abolished by deubiquiti-
nase treatment, arguing strongly against
ATG8 ubiquitination as the cause (Nguyen
et al., 2021). Everything considered, the
most plausible explanation is that ATG8
itself undergoes covalent linkage to cellular
proteins, akin to ubiquitin and NEDD8
modifiers, which are structurally similar to
ATG8s. Remarkably, the protease ATG4 an-
tagonizes the ATG8ylation state of many
proteins (Agrotis et al., 2019; Nguyen et al.,
2021).
ATG4 displays isoform-specific
proteolytic cleavage of ATG8
ATG4 is required for the formation of au-
tophagosomes, but its protease activity is
not (Nguyen et al., 2021). The protease ac-
tivity of ATG4 is, however, required for
ATG8 processing, such as priming ahead of
lipidation and de-lipidation, which removes
excess ATG8 from autophagosomes and
other membranes (Nguyen et al., 2021; Tanida
et al., 2004; Fig. 1 A). Apart from these func-
tions, ATG4 regulates the deubiquitinase-
like removal of ATG8 from cellular proteins
(de-ATG8ylation; Agrotis et al., 2019; Nguyen
et al., 2021; Fig. 1 A). Consistent with this role,
deletion of all four ATG4 isoforms (A, B, C,
and D) increases the abundance of ATG8y-
lated proteins (Nguyen et al., 2021). In con-
trast, overexpression of ATG4B has the
opposite effect, but only if its protease
activity is intact (Agrotis et al., 2019). As
such, ATG4 inhibits the ATG8ylation state
of many proteins, which is likely to modu-
late their downstream functions.
ATG4 is an important “gatekeeper” for
ATG8 conjugation events. ATG4 primes
ATG8s to expose their C-terminal glycine,
which is required for conjugation to pro-
teins or lipids; however, ATG4 also catalyzes
de-ATG8ylation and de-lipidation events,
respectively (Agrotis et al., 2019; Nguyen
et al., 2021; Tanida et al., 2004). Because
the C-terminal glycine of a single ATG8 is
occupied when conjugated to a protein or
lipid, it is unlikely that ATG8ylated proteins
directly engage with phagophore mem-
branes in the same way as ATG8-II. Indeed,
protease protection assays with recombi-
nant ATG4B reveal that de-ATG8ylation of
cell lysates remains unchanged with or
without organellar membrane disruption,
suggesting that ATG8ylated proteins are
largely cytoplasmic facing rather than in-
traluminal (Agrotis et al., 2019). Paradoxi-
cally, however, ATG8ylation is enhanced by
lysosomal V-type ATPase inhibition, which
blocks the degradation of lysosomal con-
tents, indicating that ATG8ylated substrates
may undergo lysosome-dependent turnover
(Agrotis et al., 2019; Nguyen et al., 2021).
One explanation for these differences may
be that the process of ATG8ylation is itself
sensitive to lysosomal dysfunction.
Functional relationships between
ATG4s and ATG8s
Isoforms of ATG4 show clear preferences
for proteolytically processing ATG8 sub-
families (i.e., LC3s and GABARAPs) for de-
ATG8ylation and priming upstream of
phosphatidylethanolamine ligation (Agrotis
et al., 2019; Li et al., 2011; Nguyen et al.,
2021; Fig. 1 B). ATG4A strongly reduces the
abundance of proteins that have been AT-
G8ylated with the GABARAP family while
Figure 1. The many roles of ATG4 in ATG8 processing. (A)Molecular processing of ATG8 proteins by
ATG4 illustrating its roles in priming, de-lipidation, and de-ATG8ylation. The structure of LC3B (Protein
Data Bank accession no. 1V49) was used to denote ATG8 (G, glycine; PE, phosphatidylethanolamine).
(B) Heatmap summarizing relationships between ATG4 isoforms and ATG8 family members. Data were
summarized for qualitative interpretation (Agrotis et al., 2019; Li et al., 2011; Nguyen et al., 2021). Int.,
intermediate; N.d., not determined. (C) Graphical summary of questions moving forward with ATG8y-
lation (P, phosphorylation).
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promoting ligation of GABARAPs to phos-
phatidylethanolamine (Agrotis et al., 2019;
Nguyen et al., 2021; Fig. 1 B). In contrast,
ATG4B strongly reduces the abundance of
proteins that have been ATG8ylated with
LC3 proteins while promoting ligation of
LC3s to phosphatidylethanolamine (Agrotis
et al., 2019; Nguyen et al., 2021; Fig. 1 B). In
comparison, ATG4C and -D lack obvious
de-ATG8ylation activity, although the
latter weakly promotes phosphatidyleth-
anolamine ligation to GABARAPL1 only
(Nguyen et al., 2021). These functional
similarities between ATG4 isoforms are
consistent with both their sequence and
structural homology (i.e., ATG4A and -B
are most similar; Maruyama and Noda,
2018; Satoo et al., 2009). Structurally,
ATG4B adopts an auto-inhibited con-
formation with its regulatory loop and
N-terminal tail blocking substrate entry to its
proteolytic core (Maruyama and Noda, 2018).
LC3B induces conformational rearrange-
ments in ATG4B that involve displacement of
its regulatory loop and its N-terminal tail,
with the latter achieved by an interaction
between the ATG8-interacting region in its
N-terminal tail with a second copy of LC3B
that functions allosterically (Maruyama and
Noda, 2018; Satoo et al., 2009). These re-
arrangements permit entry of LC3B into the
proteolytic core of ATG4B, where cleavage of
LC3B following its C-terminal glycine occurs
(Li et al., 2011; Maruyama and Noda, 2018).
ATG4BL232 is directly involved in LC3B bind-
ing and its selectivity for LC3s (Satoo et al.,
2009). This residue corresponds to ATG4AI233
and, when substituted for leucine, gives
ATG4AI233L the ability to efficiently process
LC3 proteins, whereas without this muta-
tion it preferentially processes GABARAPs
(Satoo et al., 2009). Moreover, the ATG8–
ATG4 interaction is necessary for the de-
ATG8ylation of cellular proteins, as an
LC3B-GQ116P mutant that cannot bind to
ATG4 leads to widespread ATG8ylation
(Agrotis et al., 2019). Altogether, these
observations hint toward a common
mechanism of ATG8 cleavage that reg-




ATG8ylation of cellular proteins appears to
be enhanced by mitochondrial depolariza-
tion and inhibition of the lysosomal V-type
ATPase (Agrotis et al., 2019; Nguyen et al.,
2021). This may be the consequence of acute
ATG4A and -B inhibition, given that cells
lacking all ATG4 isoforms display an in-
creased abundance of ATG8ylated proteins
and are insensitive to further increase by
mitochondrial depolarization or lysosomal
V-type ATPase inhibition (Agrotis et al.,
2019; Nguyen et al., 2021). Indeed, mito-
chondrial depolarization leads to activation
of ULK1, which phosphorylates ATG4BS316 to
inhibit its protease activity (Pengo et al.,
2017). Similarly, mitochondrial depolariza-
tion stimulates TBK1 activation, which pre-
vents de-lipidation of ATG8s by blocking the
ATG8–ATG4 interaction through phosphor-
ylation of LC3CS93/S96 and GABARAP-
L2S87/S88 (Herhaus et al., 2020; Richter et al.,
2016). As such, ATG8 phosphorylation may
render ATG8ylated substrates more resis-
tant to de-ATG8ylation by ATG4s. This may
be analogous to how chains of phosphory-
lated ubiquitinS65 are more resistant to hy-
drolysis by deubiquitinating enzymes than
unphosphorylated ones (Wauer et al., 2015).
Moreover, ATG8ylation is insensitive to
nutrient deprivation and pharmacologi-
cal inhibition of mTOR, which rules out a
functional contribution of this process
to starvation-induced autophagy (Agrotis
et al., 2019). Therefore, ATG8ylation may
be a unique aspect of mitophagy (and
perhaps also other forms of selective autoph-
agy) given that depolarization potently acti-
vates Parkin-dependent mitophagy (Agrotis
et al., 2019; Nguyen et al., 2021).
Substrates of ATG8ylation
Based on ATG8+ smearing, ATG4 regulates
the de-ATG8ylation of numerous proteins
(Agrotis et al., 2019; Nguyen et al., 2021).
For the majority, their identity, induced
structural and functional changes, and the
cellular contexts during which these mod-
ifications occur await exploration. Consid-
ering that the ATG8 interactome is well
characterized, it is likely that at least some
ATG8ylated proteins have been mistaken
for ATG8-binding partners (Behrends et al.,
2010). Given their E2- and E3-like roles in
ATG8 lipidation, it is remarkable that ATG3
and ATG16L1 are themselves modified by
ATG8ylation (Agrotis et al., 2019; Hanada
et al., 2007; Ichimura et al., 2000; Nguyen
et al., 2021). Lysine mutagenesis indicates
that ATG3K243 is the “acceptor” site for
ATG8ylation (Agrotis et al., 2019). ATG3K243 is
essential for its conjugation to either LC3B or
ATG12 and is required for autophagosomes to
form around damaged mitochondria (Agrotis
et al., 2019; Radoshevich et al., 2010). This
also raises the possibility that key functions
originally attributed to ATG3–ATG12 conju-
gation may be, at least in part, due to
ATG3–ATG8 conjugation. Because multi-
ple high-molecular-weight species of ATG3
are enriched following immunoprecipita-
tion of primed LC3B-G from cells lacking
ATG4B, it is likely that ATG3 is either mono-
ATG8ylated at several sites or poly-ATG8ylated
(Agrotis et al., 2019). ATG8ylation of ATG3
may also reflect the stabilization of its
E2-like intermediate (Ichimura et al., 2000).
ATG8ylation of ATG16L1 may regulate
whether canonical or noncanonical autoph-
agy pathways are activated (Durgan et al.,
2021; Nguyen et al., 2021). In line with this
possibility, the WD40 domain mutant of
ATG16L1K490A prevents lipidation of ATG8s
with phosphatidylserine (i.e., during non-
canonical autophagy pathways) but not
phosphatidylethanolamine (i.e., during ca-
nonical autophagy; Durgan et al., 2021).
Moreover, given that ATG8ylation of pro-
tein targets correlates with the activation
of mitophagy, it is tempting to speculate
that it may stimulate the E2-/E3-like ac-
tivity of the ATG8 conjugation machinery
to amplify mitochondrial capture and
destruction.
Concluding remarks
The finding that numerous cellular proteins
are modified by ATG8ylation poses several
questions about how signaling networks
are coordinated during selective autophagy
(i.e., mitophagy). Whether ATG8ylation is
augmented by mitochondrial injury per se
or is the consequence of mitophagy activa-
tion is yet to be determined, as is whether
this phenomenon occurs during other types
of selective autophagy (e.g., ER-phagy, ri-
bophagy, and lysophagy; Kirkin and Rogov,
2019; Fig. 1 C). While the in vivo relevance of
ATG8ylation is not yet understood, it is
plausible that this process could be altered
in diseases with defective mitophagy (e.g.,
Parkinson’s disease and atherosclerosis).
Exploring the mechanistic aspects of
ATG8ylation (e.g., ATG8 ligases and regula-
tory proteins, linkage types, acceptor sites,
etc.) and de-ATG8ylation byATG4will improve
our understanding about how this modifier al-
ters the structure and biological function of
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cellular proteins (Fig. 1 C). By identifying
ATG8ylated substrates, or the ATG8y-
lome, insights into whether ATG8ylation
is a ubiquitous epiphenomenon or a post-
translational modification that is selective
to proteins of distinct biological function(s)
will become clearer (Fig. 1 C). Considering
the similarity of ATG8s with bona fide
modifier proteins (e.g., ubiquitin and ubiquitin-
like proteins) and the diversity of their
substrates (e.g., lipid species and pro-
teins), only now are we beginning to un-
derstand the functional complexities of
the ATG8 protein family.
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